Coultreon

Series-A
coultreon.com Biotech & Healthcare
Total Funding $125M
Latest Round $125M Series-A
Last Announced Apr 28, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Coultreon

Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website coultreon.com
Domain Registered Date Mar 16, 2026

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $125,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    coultreon.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Coultreon.

Funding History

1 Round
Series-A · Apr 28, 2026

Founders & Leadership

6

Fabrice Kolb

Head of Immunology Co-founder

Work email & phone locked Unlock →

Guy Peeters

Chief Financial Officer Co-founder

Work email & phone locked Unlock →

John-Paul Gallivan

Head of Development Co-founder

Work email & phone locked Unlock →

Marie De Vulder

Chief Legal Officer Co-founder

Work email & phone locked Unlock →

Pierre Raboisson

Chief Executive Officer Chief Scientific Officer Co-founder

Work email & phone locked Unlock →

Pieter Peeters

Operating & Technology Officer Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts